0001171843-15-004863.txt : 20150824 0001171843-15-004863.hdr.sgml : 20150824 20150824163425 ACCESSION NUMBER: 0001171843-15-004863 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150820 FILED AS OF DATE: 20150824 DATE AS OF CHANGE: 20150824 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOMEDICS INC CENTRAL INDEX KEY: 0000722830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 611009366 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 BUSINESS PHONE: 9736058200 MAIL ADDRESS: STREET 1: 300 AMERICAN ROAD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDENBERG CYNTHIA L CENTRAL INDEX KEY: 0001202016 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12104 FILM NUMBER: 151071334 MAIL ADDRESS: STREET 1: C/O XIMMUNOMEDICS INC STREET 2: 300 AMERICAN RD CITY: MORRIS PLAINS STATE: NJ ZIP: 07950 FORMER NAME: FORMER CONFORMED NAME: SULLIVAN CYNTHIA L DATE OF NAME CHANGE: 20021029 4 1 formfour.xml X0306 4 2015-08-20 0 0000722830 IMMUNOMEDICS INC IMMU 0001202016 GOLDENBERG CYNTHIA L C/O IMMUNOMEDICS, INC. 300 THE AMERICAN ROAD MORRIS PLAINS NJ 07950 1 1 0 0 President and CEO Common Stock 2015-08-20 4 A 0 198864 0 A 759873 D Common Stock 5398127 I See footnote. Stock Option (right to buy) 1.76 2015-08-20 4 A 0 408163 A 2022-08-20 Common Stock, par value $0.01 per share 408163 408163 D Such restricted stock units were granted pursuant to the Immunomedics, Inc. 2014 Long-Term Incentive Plan, and vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter. Includes a total of 190,000 shares held as joint tenants by the reporting person and her spouse, David M. Goldenberg, the Issuer's Chief Scientific Officer, Chief Patent Officer, and Chairman of the Board of Directors. Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is an officer. The reporting person disclaims beneficial ownership of these shares except to the extent of her pecuniary interests therein. Such stock options were granted pursuant to the Immunomedics, Inc. 2014 Long-Term Incentive Plan, and vest 25% on the first anniversary of the date of grant and 6.25% on a quarterly basis thereafter. /s/ Cynthia L. Goldenberg 2015-08-24